National Community Pharmacists Association CEO B. Douglas Hoey, RPh, MBA, issued the following statement today in response to the detailed "preferred pharmacy" access analysis released by the Centers for Medicare & Medicaid Services.
The National Association of Chain Drug Stores is hailing progress in the effort to spur collaboration among health and enforcement authorities for drug abuse solutions that maintain patients’ legitimate access to medications.
The Generic Pharmaceutical Association welcomes efforts in the Obama administration’s FY2017 budget to improve access to more affordable generic medicines.
“The Generic Pharmaceutical Association and its Biosimilars Council commend the Food and Drug Administration for hosting today’s Arthritis Advisory Committee Meeting on the infliximab biosimilar, an important step toward advancing science and encouraging more choices for patients who previously would have to rely on costly brand biologic medicines.
Policy and political analysis and idea-sharing are in full swing at the NACDS Regional Chain Conference – which focuses on the needs of National Association of Chain Drug Stores (NACDS) chain-member companies that operate from four to 250 stores each, as well as their supplier partners.